Pfizer's innovative business should grow faster after it divests its off-patent division Upjohn in 2020 to create Viatris and ...

Pfizer reported a strong sales performance for its antifungal drug Cresemba in the Asia Pacific and China, thanks to a ...

U.S. research on HIV, tuberculosis, Covid-19, mpox, and other fast-moving epidemics is under threat by a hastily announced ...

Jefferies reaffirms its Buy rating on Pfizer and sticks to a $33 target, calling the stock undervalued at $23.35. Their ...

It has long been acknowledged that the global health system needs reform. Although this system has improved public health, ...

Investors are being drawn to services and other sectors that are more immune to global tariffs, as volatility weighs down ...

Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...

FUJIFILM Corporation's Life Sciences Group companies, a portfolio of businesses offering products, services and comprehensive ...

Under terms of the deal, Bristol Myers will pay $1.5 billion upfront, and a total of $2 billion in anniversary payments for the next few years to co-develop and co-sell BioNTech's BNT327 for the ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Pfizer Inc. (NYSE: PFE) is navigating a period of strategic upheaval and legal scrutiny as it ends its clinical collaboration ...